Reaching Precision in Cancer Therapy Through Patient-Derived MicroOrganoSpheres, Flow Cytometry Analysis, and Molecular Profiling

Join a 43-minute webinar featuring Dr. David Hsu and Dr. Ryan Mote as they explore groundbreaking developments in precision cancer therapy. Discover how patient-derived tumor models, specifically the innovative MicroOrganoSphere™ (MOS™) 3-D tissue model, are revolutionizing gastrointestinal cancer treatment. Learn about the integration of advanced technologies, including the SH800 Cell Sorter and 10x Genomics' Single Cell 3' chemistry, in analyzing and validating these miniature tumor models. Gain insights into how these personalized approaches predict therapy responses and improve treatment outcomes. Explore the ongoing clinical trials at Duke University for colorectal cancer using this promising technology. Master the innovative features of MOS, understand their accuracy in representing patient tumor landscapes, and compare them with conventional cancer treatments. Examine how cutting-edge genomics technology and cell sorting capabilities contribute to developing precise, patient-specific cancer therapies.